Invention Grant
- Patent Title: Fibronectin targeting contrast agent
- Patent Title (中): 纤连蛋白靶向造影剂
-
Application No.: US13071596Application Date: 2011-03-25
-
Publication No.: US09011816B2Publication Date: 2015-04-21
- Inventor: Zheng-Rong Lu , Xueming Wu
- Applicant: Zheng-Rong Lu , Xueming Wu
- Applicant Address: US OH Cleveland
- Assignee: Case Western Reserve University
- Current Assignee: Case Western Reserve University
- Current Assignee Address: US OH Cleveland
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14 ; A61K49/14 ; A61K49/12 ; A61K51/06 ; A61K51/08

Abstract:
Example systems and methods enhance contrast in MRI images. To facilitate imaging of atherosclerotic plaques, arterial and venous, cardiac, and even tumor tissues and fibrosis, a fibrin-fibronectin complex or disease-related fibronectin specific MRI contrast agent (CLPD) has a specific binding affinity for fibronectin.
Public/Granted literature
- US20120244070A1 FIBRONECTIN TARGETING CONTRAST AGENT Public/Granted day:2012-09-27
Information query